GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » 4DMedical Ltd (ASX:4DX) » Definitions » COGS-to-Revenue

4DMedical (ASX:4DX) COGS-to-Revenue : 0.06 (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is 4DMedical COGS-to-Revenue?

4DMedical's Cost of Goods Sold for the six months ended in Dec. 2023 was A$0.05 Mil. Its Revenue for the six months ended in Dec. 2023 was A$0.79 Mil.

4DMedical's COGS to Revenue for the six months ended in Dec. 2023 was 0.06.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. 4DMedical's Gross Margin % for the six months ended in Dec. 2023 was 93.57%.


4DMedical COGS-to-Revenue Historical Data

The historical data trend for 4DMedical's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4DMedical COGS-to-Revenue Chart

4DMedical Annual Data
Trend Jun21 Jun22 Jun23
COGS-to-Revenue
0.42 0.73 0.12

4DMedical Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
COGS-to-Revenue Get a 7-Day Free Trial 0.38 0.80 0.07 - 0.06

4DMedical COGS-to-Revenue Calculation

4DMedical's COGS to Revenue for the fiscal year that ended in Jun. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0.034 / 0.282
=0.12

4DMedical's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0.051 / 0.793
=0.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


4DMedical  (ASX:4DX) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

4DMedical's Gross Margin % for the six months ended in Dec. 2023 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 0.051 / 0.793
=93.57 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


4DMedical COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of 4DMedical's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


4DMedical (ASX:4DX) Business Description

Traded in Other Exchanges
Address
700 Swanston Street, Level 7, Melbourne Connect, Carlton, VIC, AUS, 3053
4DMedical Ltd is a company whose principal activities is medical research technology and the development of a non?invasive respiratory imaging solution using four?dimensional imaging. The four-dimensional lung imaging technology utilises mathematics models and algorithms to convert X-ray scans into quantitative data which helps the physicians to manage patients with respiratory diseases and diseases of the lung.

4DMedical (ASX:4DX) Headlines

No Headlines